

Immunity is not defined by individual cells alone, but by the tissue environment in which they reside.
From this perspective, we are pioneering a new frontier in immunology.
At the Kurashima Laboratory (Department of International Allergy and Mucosal Immunology / Department of Innovation Medicine),
we focus on the mucosa, the frontline of immune defense.
By elucidating the complex tissue environment shaped by immune cells, mesenchymal (structural) cells, epithelial cells, neurons, and the microbiota, we aim to develop new strategies for the prevention, diagnosis, and treatment of allergy and inflammatory diseases.
While conventional immunology has largely centered on immune cells, our approach emphasizes the diverse cellular components that constitute tissues and their dynamic interactions. In particular, we have demonstrated that mesenchymal (structural) cells, traditionally regarded as merely supportive, play a pivotal role in directing immune responses.
Furthermore, we are uncovering how multi-layered networks—including inter-organ communication (especially involving the gut), neuro-immune crosstalk, and host–microbiota interactions—govern immune homeostasis and the onset of disease.
Three Research Projects
1. SCAI Project
Structural Cells Affect/Ameliorate Immunity, Infection and Inflammation
Focusing on the tissue-specific influence of mesenchymal (structural) cells on immunity, this project aims to elucidate their multifaceted roles, including:
Through these approaches, we seek to establish new strategies for controlling inflammatory and fibrotic diseases.
The gut does not function as an isolated organ, but rather as part of a system-wide network of interacting organs.
In this project, we aim to elucidate the mechanisms by which organ networks—including the microbiota, nervous system, and pancreas—
cooperatively regulate the intestinal environment, based on the concept of organ crosstalk.
In inflammatory bowel disease (IBD), we have identified a phenomenon in which the tissue invasion of pathogenic microbiota is controlled through coordinated interactions among multiple organs.
Building on this finding, we are advancing a new conceptual framework of “disease regulation through organ networks”, and exploring its translational applications.
Allergy is not an uncontrollable response.
In this project, we focus on the plasticity of immune cells to elucidate the mechanisms of an “immune switch” that transitions from an
allergy-inducing state (ON) to a state that suppresses allergy and inflammation (OFF).
By uncovering the mechanisms underlying the functional reprogramming of immune cells, including mast cells, we aim to establish novel therapeutic strategies that enable the fundamental control of allergic diseases.
These research programs are conducted in close collaboration with the Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), with a clear vision spanning from basic science to clinical and societal implementation.
Our work is being translated into next-generation medical technologies, including mucosal vaccines, antibody therapeutics, and microbiota-based interventions.
We value cross-disciplinary challenges and open, dynamic discussions.
We warmly welcome research students, undergraduate and graduate students, postdoctoral fellows, and collaborative research partners.
If you share this vision, we would be delighted to work together.
We sincerely welcome inquiries regarding lab visits and collaborative opportunities.